Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Personalizable pessary for pelvic organ prolapse

Official title: Evaluation of a Novel Personalizable Pessary for the Treatment of Pelvic Organ Prolapse

Run by University of Alberta · NCT06954701 · Data updated 2026-11-12

A new, custom-fit pessary made with 3D printing will be tested to see if it works as well as standard pessaries for women with pelvic organ prolapse.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment43 (estimated)
SponsorUniversity of Alberta
Academic / other
Locations1 site (Edmonton, Alberta)
StatusRecruiting
StartedApril 30, 2026
Main results expectedOctober 2026
Study endsOctober 2026
Registry record updatedJune 4, 2026
Trial IDNCT06954701 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older with symptomatic pelvic organ prolapse using a pessary for at least 3 months.

Probably not a fit

Those who do not experience adequate relief or who have contraindications or intolerance to pessaries may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests a novel personalizable pessary designed to match the natural shape of the vagina and be easier to remove and reinsert. It compares the personalizable pessary to standard pessaries in terms of efficacy and safety for treating pelvic organ prolapse. Eligible participants are adults with symptomatic prolapse who have been using a pessary for at least 3 months. The trial aims to determine non-inferiority in symptom relief while monitoring adverse events and device-related issues. Recruitment is centered at the University of Alberta and affiliated centers in Edmonton, Canada.

Why it matters

Potential benefit: If successful, the personalizable pessary could improve fit, comfort, and continuation rates, reducing symptoms and need for surgical intervention.

How similar studies have gone: Previous pessaries have had limited fit and adherence, but 3D-printed, personalized designs are a newer approach with early exploratory evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients assigned female at birth
* At least 18 years old at time of screening
* Patients with symptomatic POP using a pessary for ≥ 3 months
* Capable of giving informed consent
* Fluency in English

Exclusion Criteria:

* Pregnancy
* Short vaginal length (total vaginal length \<5 cm) or subjective vaginal narrowing
* Vaginal erosion due to current pessary
* Presence of vesicovaginal fistula
* Presence of rectovaginal fistula
* Current treatment for vaginal, rectal, or bladder tumor
* Presence of open wound or tear near vagina or anus by exam prior to removal of current pessary
* Presence of pelvic, vaginal, or urinary infection requiring treatment
* Ongoing treatment of recurrent urinary tract or vaginal infections
* Inflammatory bowel disease
* Chronic pain syndromes of pelvic or anorectal origin
* Previous pelvic floor surgery in last 12 months
* Congenital malformation of bladder, rectum, or vagina
* Significant medical condition interfering with study participation (psychologic, neurologic, active drug/alcohol abuse, ambulatory restrictions, etc.)
* Planning pregnancy in next 6 months

Where it's running

  • Dale Sheard Centre for Solutions in Women's Health
    Edmonton, Alberta, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.